The global depression treatment market, valued at USD 11 billion in 2024, is poised for steady growth, projected to reach USD 18.3 billion by 2034 at a CAGR of 5.2%. This expansion is driven by ...
The Schedule III substance was approved by the FDA in the 1970s for the induction and maintenance of anesthesia, but it ...
Southern Charm star Molly O'Connell is getting candid on how ketamine infusions "completely changed" her life. "I was in a ...
Southern Charm star Molly O’Connell is getting candid on how ketamine infusions “completely changed” her life. “I was in a ...
Ketamine has long been used in medical settings as an anesthetic and painkiller, particularly in emergency cases where other ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...